Table 1:
Parameter | Training Group | Testing Group | Total |
---|---|---|---|
Patient demographics | |||
No. of patients | 212 | 54 | 266 |
Mean age (y)* | 57 ± 14 | 62 ± 12 | 60 ± 14 |
M/F ratio | 93:119 | 25:29 | 118:148 |
Magnetic field strength | |||
1.5 T | 197 | 49 | 246 |
3.0 T | 15 | 5 | 20 |
Primary cancer types | |||
Lung | 79 (37) | 23 (43) | 102 (38) |
Melanoma | 43 (20) | 12 (22) | 55 (21) |
Breast | 38 (18) | 6 (11) | 44 (16) |
Renal | 25 (12) | 3 (5.6) | 28 (11) |
Gastrointestinal | 9 (4.2) | 2 (3.7) | 11 (4.1) |
Genitourinary | 6 (2.8) | 1 (1.8) | 7 (2.6) |
Sarcoma | 5 (2.4) | 0 (0.0) | 5 (1.9) |
Thyroid | 2 (1.0) | 2 (3.7) | 4 (1.5) |
Testicular | 2 (1.0) | 2 (3.7) | 4 (1.5) |
Head and neck | 2 (1.0) | 2 (3.7) | 4 (1.5) |
Neuroendocrine carcinoma | 1 (0.5) | 1 (1.8) | 2 (0.8) |
Note.—Except where indicated, data are numbers of patients, with percentages in parentheses.
Data are means ± standard deviation.